Are selective COX 2 inhibitors superior to traditional NSAIDs? Pharmacia's response to editorial.
G Steven
GS
Geis
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D001241:Aspirin / Q000009:adverse effects; D000068579:Celecoxib; D002986:Clinical Trials as Topic; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D004008:Diclofenac / Q000009:adverse effects; D004359:Drug Therapy, Combination; D006801:Humans; D007052:Ibuprofen / Q000009:adverse effects; D010437:Peptic Ulcer / Q000139:chemically induced*; D011720:Pyrazoles; D013449:Sulfonamides / Q000009:adverse effects*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D011720:Pyrazoles; D013449:Sulfonamides; D004008:Diclofenac; D000068579:Celecoxib; D001241:Aspirin; D007052:Ibuprofen